Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA 510(k) approval for Fresenius:

This article was originally published in Clinica

Executive Summary

Fresenius USA's On Line Clearance monitor has received a 510(k) marketing clearance from the FDA. Used in conjunction with hemodialysis equipment, the device monitors the dose of dialysis achieved for end-stage renal disease patients during renal replacement therapy. This allows immediate treatment adjustment and eliminates monthly blood treatment sampling and testing for results. Fresenius USA is a subsidiary of Fresenius Medical North America.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT086577

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel